alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 16,651–16,675 of 27,380 studies, newest first · page 667 of 1096.

September 2015 25

  1. 2015-09-30

    The Vallecas Project: A Cohort to Identify Early Markers and Mechanisms of Alzheimer's Disease

    ✓ Peer-reviewed Digital health tools Frontiers in aging neuroscience

    Key finding: We have established a valuable homogeneous single-center cohort which, by identifying groups of variables associated with high risk of MCI or dementia conversion, should help to clarify the early physiopathological mechanisms of AD and should provide avenues for prompt diagnosis and AD prevention. +1 more finding

    Full summary, score breakdown and related studies → Original source

  2. 2015-09-29

    Astrocytic estrogen receptors and impaired neurotrophic responses in a rat model of perimenopause

    ✓ Peer-reviewed Biomarkers Frontiers in aging neuroscience

    Key finding: These findings are relevant to impairments of spatial learning and of hippocampal long-term potentiation during the onset of IR in middle-aged rats, and to perimenopausal factors mediating the higher risk of women for Alzheimer disease.

    Full summary, score breakdown and related studies → Original source

  3. 2015-09-28

    CD33 modulates TREM2: convergence of Alzheimer loci

    ✓ Peer-reviewed Risk genes beyond APOE Nature neuroscience

    Key finding: The NME8 locus influenced PTK2B and the CD33 risk allele led to greater TREM2 expression. +1 more finding

    Full summary, score breakdown and related studies → Original source

  4. 2015-09-28

    Dementia in older people admitted to hospital: a regional multi-hospital observational study of prevalence, associations and case recognition

    ✓ Peer-reviewed Disparities Age and ageing

    Key finding: Previous studies have indicated a prevalence of dementia in older admissions of ∼42% in a single London teaching hospital, and 21% in four Queensland hospitals.

    Full summary, score breakdown and related studies → Original source

  5. 2015-09-25

    A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin

    ✓ Peer-reviewed Tau biomarkers Neurobiology of aging

    Key finding: CSF, but not plasma, CLU levels were significantly associated with AD status and CSF tau/amyloid-beta ratio, and highly correlated with CSF apolipoprotein E (APOE) levels. +2 more findings

    Full summary, score breakdown and related studies → Original source

  6. 2015-09-25

    Anti-Aβ Autoantibodies in Amyloid Related Imaging Abnormalities (ARIA): Candidate Biomarker for Immunotherapy in Alzheimer's Disease and Cerebral Amyloid Angiopathy

    ✓ Peer-reviewed Treatments Frontiers in neurology

    Key finding: Amyloid-related imaging abnormalities (ARIA) represent the major severe side effect of amyloid-beta (Aβ) immunotherapy for Alzheimer's disease (AD). +3 more findings

    Full summary, score breakdown and related studies → Original source

  7. 2015-09-25

    EEG characteristics in "eyes-open" versus "eyes-closed" conditions: Small-world network architecture in healthy aging and age-related brain degeneration

    ✓ Peer-reviewed Mild cognitive impairment Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology

    Key finding: In resting state condition, aMCI small-world architecture presents midway topological properties between AD subjects and healthy controls, confirming the hypothesis that aMCI is an intermediate step along the disease progression.

    Full summary, score breakdown and related studies → Original source

  8. 2015-09-25

    ESPEN guidelines on nutrition in dementia

    ✓ Peer-reviewed Caregiving Clinical nutrition (Edinburgh, Scotland)

    Key finding: Nutritional care and support should be an integral part of dementia management. +1 more finding

    Full summary, score breakdown and related studies → Original source

  9. 2015-09-25

    Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue

    ✓ Peer-reviewed Getting a diagnosis Annals of neurology

    Key finding: Our data suggest that [F-18]-AV-1451 holds promise as a surrogate marker for the detection of brain tau pathology in the form of tangles and paired helical filament-tau-containing neurites in Alzheimer brains but also point to its relatively lower affinity for lesions primarily made of straight tau filaments in non-Alzheimer tauopathy cases and to the existence of some [F-18]-AV-1451 off-target binding. +2 more findings

    Full summary, score breakdown and related studies → Original source

  10. 2015-09-23

    Magnesium in Prevention and Therapy

    ✓ Peer-reviewed Risk factors Nutrients

    Key finding: Imbalances in magnesium status-primarily hypomagnesemia as it is seen more common than hypermagnesemia-might result in unwanted neuromuscular, cardiac or nervous disorders. +1 more finding

    Full summary, score breakdown and related studies → Original source

  11. 2015-09-21

    Cognitive impairment in Parkinson's disease and dementia with Lewy bodies

    ✓ Peer-reviewed Prevention trials Parkinsonism & related disorders

    Key finding: Compared to the many treatments available for motor symptoms, relatively few systematic studies exist to guide the treatment of cognitive impairment in PD, and even less in DLB. +1 more finding

    Full summary, score breakdown and related studies → Original source

  12. 2015-09-21

    Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits

    ✓ Peer-reviewed Lewy body dementia Nature medicine

    Key finding: The acetyl-mimicking mutant K174Q slows tau turnover and induces cognitive deficits in vivo. +4 more findings

    Full summary, score breakdown and related studies → Original source

  13. 2015-09-17

    End of life care interventions for people with dementia in care homes: addressing uncertainty within a framework for service delivery and evaluation

    ✓ Peer-reviewed End-of-life care BMC palliative care

    Key finding: For people with dementia living and dying in care homes, EoL interventions need to provide strategies that can accommodate or "hold" the inevitable and often unresolvable uncertainties of providing and receiving care in these settings. +1 more finding

    Full summary, score breakdown and related studies → Original source

  14. 2015-09-17

    Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort

    ✓ Peer-reviewed Mild cognitive impairment Alzheimer's research & therapy

    Key finding: CSF levels of YKL-40 may have utility for discriminating between cognitively normal individuals and patients with MCI or AD. +1 more finding

    Full summary, score breakdown and related studies → Original source

  15. 2015-09-16

    Computerised cognitive testing of individuals with Down's syndrome and Alzheimer's disease

    ✓ Peer-reviewed Cognitive tests and assessment Journal of intellectual disability research : JIDR

    Key finding: Mean scaled scores in this longitudinal study were evaluated with repeated measures analysis of variance. +3 more findings

    Full summary, score breakdown and related studies → Original source

  16. 2015-09-16

    Exenatide reduces TNF-α expression and improves hippocampal neuron numbers and memory in streptozotocin treated rats

    ✓ Peer-reviewed Drug development European journal of pharmacology

    Key finding: While the brain TNF-α levels were significantly high in the saline-treated STZ group, exenatide treatment suppressed the increase in TNF-α levels. +4 more findings

    Full summary, score breakdown and related studies → Original source

  17. 2015-09-16

    Health care professionals' perspectives of advance care planning for people with dementia living in long-term care settings: A narrative review of the literature

    ✓ Peer-reviewed End-of-life care Dementia (London, England)

    Key finding: A systematic literature search identified 14 papers for inclusion. +4 more findings

    Full summary, score breakdown and related studies → Original source

  18. 2015-09-16

    Eating behavior in frontotemporal dementia: Peripheral hormones vs hypothalamic pathology

    ✓ Peer-reviewed Brain scans and imaging Neurology

    Key finding: In bvFTD, they are in part related to hypothalamic degeneration, with potential disintegration of the network connections between the hypothalamus and orbitofrontal cortex/reward pathways.

    Full summary, score breakdown and related studies → Original source

  19. 2015-09-15

    Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease

    ✓ Peer-reviewed Disease mechanisms Brain : a journal of neurology

    Key finding: Cerebrospinal fluid neurogranin was increased in patients with Alzheimer's disease dementia (P < 0.001), progressive mild cognitive impairment (P < 0.001) and stable mild cognitive impairment (P < 0.05) compared with controls, and in Alzheimer's disease dementia (P < 0.01) and progressive mild cognitive impairment (P < 0.05) compared with stable mild cognitive impairment. +1 more finding

    Full summary, score breakdown and related studies → Original source

  20. 2015-09-15

    Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers

    ✓ Peer-reviewed Caregiving Acta neuropathologica

    Key finding: While previous studies focusing on poly-GA pathology have failed to detect any clinico-pathological correlations in C9ORF72 mutation cases, recent data from animal and cell culture models suggested that it may be only specific DPR species that are toxic and only when accumulated in certain intracellular compartments. +3 more findings

    Full summary, score breakdown and related studies → Original source

  21. 2015-09-15

    Multidomain Lifestyle Interventions for the Prevention of Cognitive Decline After Ischemic Stroke: Randomized Trial

    ✓ Peer-reviewed Treatments Stroke

    Key finding: This trial found no benefit of 24-month multidomain intervention with focus on improvement in lifestyle and vascular risk factors on the incidence of poststroke cognitive decline in comparison with standard stroke care.

    Full summary, score breakdown and related studies → Original source

  22. 2015-09-15

    The Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E

    ✓ Peer-reviewed Genetics The Journal of biological chemistry

    Key finding: These findings reveal a link between two Alzheimer disease risk factors and may provide important clues to the pathogenesis of Nasu-Hakola disease and other neurodegenerative disorders.

    Full summary, score breakdown and related studies → Original source

  23. 2015-09-15

    Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)

    ✓ Peer-reviewed Genetics The Journal of biological chemistry

    Key finding: Using a biochemical assay, we demonstrated high-affinity binding of apoE to human TREM2.

    Full summary, score breakdown and related studies → Original source

  24. 2015-09-14

    Family physicians' role in palliative care throughout the care continuum: stakeholder perspectives

    ✓ Peer-reviewed End-of-life care Family practice

    Key finding: Our results help to elucidate the tasks and roles required of FPs to make integration of a palliative care approach into the care continuum possible. +1 more finding

    Full summary, score breakdown and related studies → Original source

  25. 2015-09-14

    Potentials and limits to enhance cognitive functions in healthy and pathological aging by tDCS

    ✓ Peer-reviewed Prevention trials Frontiers in cellular neuroscience

    Key finding: Although promising short-term results have been reported, evidence from randomized controlled trials (RCTs) with sufficient sample sizes is scarce.

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →